New guidelines recommend children and adolescents with cancer get regular physical activity to mitigate side effects from treatment.

by Erin O’Donnell

An mRNA vaccine with immunotherapy may lower recurrence in melanoma, and active surveillance for prostate cancer has increased in the Veterans Affairs health system over the last two decades.

by Darlene Dobkowski

Patients are waiting longer to start treatment than they did a decade ago, and an experimental pancreatic cancer drug is reaching patients ahead of FDA approval.

by Marci Landsmann

Injectable radioligand therapy approved for metastatic hormone-sensitive prostate cancer, and clinical trials test colon cancer vaccines for people with Lynch syndrome.

by Eric Fitzsimmons

Palliative care services are underused in young adults with advanced cancer, and a campaign aims to raise awareness about the fallopian tubes’ role in ovarian cancer.

by Thomas Celona

An experimental vaccine triggers an immune response in people at high risk for pancreatic cancer, and people diagnosed with cancer after visiting the emergency department may have a higher mortality rate.

by Darlene Dobkowski

A targeted therapy inhibits multiple proteins in a common signaling pathway for breast cancer, and disparities researchers feel the impact of shifting federal priorities.

by Marci A. Landsmann

A double lung transplant could extend survival for certain people with advanced lung cancer, and LGBTQ+ people are less likely to receive some cancer screenings.

by Thomas Celona

Immunotherapy lowers risk for graft-versus-host disease, and women with cancer still lack crucial fertility preservation conversations.

by Eric Fitzsimmons

A new report details persistent disparities in cancer care, and the FDA approved an antibody-drug conjugate as a first-line treatment for advanced triple-negative breast cancer.

by Darlene Dobkowski